These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The management of depression: the implications for managed care--roundtable discussion: Part 2.
    Author: Arikian S, Casciano J, Kang-Cipolla L, Vodoor M, Grubin M, Clark D, Waugh W, Kelsey J, Osborn LW.
    Journal: Manag Care Interface; 2000; Suppl B():19-25, 32. PubMed ID: 11183021.
    Abstract:
    One of the most commonly utilized drug classes today is antidepressant therapy, which accounts for billions of dollars in spending. Pharmacoeconomic tools may play an influential role in formulary decision making, particularly in this drug class. In part 2 of the roundtable discussion, a pharmacoeconomic model is presented that may clarify the health economic effects of placing serotonin-norepinephrine reuptake inhibitors on the drug formulary, particularly in the context of other antidepressant medications.
    [Abstract] [Full Text] [Related] [New Search]